It was indicated that TPD52 expression in ovarian cancer tissue was higher compared with normal ovarian epithelium [28], and TPD52 was found to be overexpressed in prostate cancer [29,30] and breast cancer [31,32]. Here, TPD52 is linked to ovarian cancer.